Immune regulation and CNS autoimmune disease.
The central nervous system is a demonstrated target of both clinical and experimental immune mediated disorders. Immune regulatory mechanisms operative at the levels of the systemic immune system, the blood brain barrier, and within the CNS parenchyma are important determinants of the intensity and duration of the tissue directed injury. Convergence of research, involving direct manipulation of specific cells and molecular mediators in animal models and in vitro analysis of human immune and neural cells and tissues, is providing increasing insight into the role of these immune regulatory functions and their potential to serve as therapeutic targets.
Antel
J P
JP
Neuroimmunology Unit, Montreal Neurological Institute, QC, Canada. mdan@musica.mcgill.ca
Owens
T
T
D000818:Animals; D017951:Antigen Presentation / Q000276:immunology; D001253:Astrocytes / Q000276:immunology; D001812:Blood-Brain Barrier / Q000276:immunology; D002144:Callithrix; D020278:Demyelinating Autoimmune Diseases, CNS / Q000276:immunology*; D006801:Humans; D008264:Macrophages / Q000276:immunology; D051379:Mice; D017628:Microglia / Q000276:immunology; D020721:Nervous System Autoimmune Disease, Experimental / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology